The Asia-Pacific Region Has the World’s Highest Burden of Hepatitis B

In a new issue brief, TREAT Asia responds to this urgent global public health emergency

In a global health emergency that gets little attention, roughly 300 million people worldwide are living with chronic hepatitis B virus (HBV) infection and 820,000 died of HBV-related complications in 2019 alone. The Asia-Pacific region bears the highest overall burden of HBV, with 59% of those living with chronic HBV, 26% of new infections, and 79% of deaths.

Vaccines and treatments for HBV infection do exist, but as of 2019 only 2% of people in Southeast Asia had been diagnosed and just 0.2% were on treatment.

In response to the urgent threat HBV poses in the Asia-Pacific region, amfAR’s TREAT Asia program has issued a brief on the scope of the problem and what’s needed for the prevention, care, and treatment of people at risk for or impacted by HBV.

Read the brief here.

TREAT Asia Responds to Hepatitis B Public Health Emergency

Share This: